Norman W Barton, MD, PhD - Publications

2013-2018 Neuroscience Shire 
 2018- Rare Diseases Takeda 
Leukodystrophies, Neurochemistry

49 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Mistry PK, Lopez G, Schiffmann R, Barton NW, Weinreb NJ, Sidransky E. Gaucher disease circa 2016: Progress and ongoing challenges. Molecular Genetics and Metabolism. PMID 27916601 DOI: 10.1016/J.Ymgme.2016.11.006  0.384
2016 Desnick RJ, Barton NW, Furbish S, Grabowski GA, Karlsson S, Kolodny EH, Medin JA, Murray GJ, Mistry PK, Patterson MC, Schiffmann R, Weinreb NJ. Roscoe Owen Brady, MD: Remembrances of co-investigators and colleagues. Molecular Genetics and Metabolism. PMID 27866832 DOI: 10.1016/J.Ymgme.2016.10.010  0.362
2013 Ben Turkia H, Gonzalez DE, Barton NW, Zimran A, Kabra M, Lukina EA, Giraldo P, Kisinovsky I, Bavdekar A, Ben Dridi MF, Gupta N, Kishnani PS, Sureshkumar EK, Wang N, Crombez E, et al. Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease. American Journal of Hematology. 88: 179-84. PMID 23400823 DOI: 10.1002/Ajh.23382  0.407
2013 Gonzalez DE, Turkia HB, Lukina EA, Kisinovsky I, Dridi MF, Elstein D, Zahrieh D, Crombez E, Bhirangi K, Barton NW, Zimran A. Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double-blind, multinational, Phase 3 study. American Journal of Hematology. 88: 166-71. PMID 23386328 DOI: 10.1002/Ajh.23381  0.37
2011 Mehta A, Turkia HB, Gonzalez D, Kabra M, Lukina E, Giraldo P, Kisinovsky I, Bavdekar A, Dridi MB, Gupta N, Kishnani P, Sureshkumar E, Barton N, Wang N, Crombez E, et al. Two-Year Safety and Tolerability of Velaglucerase Alfa in Patients with Type 1 Gaucher Disease, Including Patients Switched From Imiglucerase: Phase III Trial HGT-GCB-039 and Extension, Blood. 118: 3214-3214. DOI: 10.1182/Blood.V118.21.3214.3214  0.379
2002 Luciano CA, Russell JW, Banerjee TK, Quirk JM, Scott LJ, Dambrosia JM, Barton NW, Schiffmann R. Physiological characterization of neuropathy in Fabry's disease. Muscle & Nerve. 26: 622-9. PMID 12402283 DOI: 10.1002/Mus.10236  0.355
2002 Schiffmann R, Mankin H, Dambrosia JM, Xavier RJ, Kreps C, Hill SC, Barton NW, Rosenthal DI. Decreased bone density in splenectomized Gaucher patients receiving enzyme replacement therapy Blood Cells, Molecules, and Diseases. 28: 288-296. PMID 12064924 DOI: 10.1006/Bcmd.2002.0517  0.364
2001 Altarescu G, Hill S, Wiggs E, Jeffries N, Kreps C, Parker CC, Brady RO, Barton NW, Schiffmann R. The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease. The Journal of Pediatrics. 138: 539-47. PMID 11295718 DOI: 10.1067/Mpd.2001.112171  0.685
2000 Altarescu G, Schiffmann R, Parker CC, Moore DF, Kreps C, Brady RO, Barton NW. Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease. Blood Cells, Molecules & Diseases. 26: 285-90. PMID 11042029 DOI: 10.1006/Bcmd.2000.0310  0.625
1999 Scott LJ, Griffin JW, Luciano C, Barton NW, Banerjee T, Crawford T, McArthur JC, Tournay A, Schiffmann R. Quantitative analysis of epidermal innervation in Fabry disease. Neurology. 52: 1249-54. PMID 10214752 DOI: 10.1212/Wnl.52.6.1249  0.312
1999 Rodrigue SW, Rosenthal DI, Barton NW, Zurakowski D, Mankin HJ. Risk factors for osteonecrosis in patients with type 1 Gaucher's disease. Clinical Orthopaedics and Related Research. 362: 201-207. DOI: 10.1097/00003086-199905000-00029  0.402
1998 Argoff CE, Barton NW, Brady RO, Ziessman HA. Gastrointestinal symptoms and delayed gastric emptying in Fabry's disease: response to metoclopramide. Nuclear Medicine Communications. 19: 887-91. PMID 10581595 DOI: 10.1097/00006231-199809000-00009  0.598
1998 Dunbar CE, Kohn DB, Schiffmann R, Barton NW, Nolta JA, Esplin JA, Pensiero M, Long Z, Lockey C, Emmons RV, Csik S, Leitman S, Krebs CB, Carter C, Brady RO, et al. Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation. Human Gene Therapy. 9: 2629-40. PMID 9853529 DOI: 10.1089/Hum.1998.9.17-2629  0.601
1998 Crutchfield KE, Patronas NJ, Dambrosia JM, Frei KP, Banerjee TK, Barton NW, Schiffmann R. Quantitative analysis of cerebral vasculopathy in patients with Fabry disease Neurology. 50: 1746-1749. PMID 9633721 DOI: 10.1212/Wnl.50.6.1746  0.365
1997 Grewal RP, Yu KT, Barton NW, Parker RI, Bisceglie AMD. Liver biopsies in patients with lysosomal storage disease: experience with effective sedation. Indian Journal of Pediatrics. 64: 887-891. PMID 10771935 DOI: 10.1007/Bf02725518  0.388
1997 Brady RO, Murray GJ, Oliver KL, Leitman SF, Sneller MC, Fleisher TA, Barton NW. Management of neutralizing antibody to Ceredase in a patient with type 3 Gaucher disease. Pediatrics. 100: E11. PMID 9382912 DOI: 10.1542/Peds.100.6.E11  0.647
1997 Schiffmann R, Heyes MP, Aerts JM, Dambrosia JM, Patterson MC, DeGraba T, Parker CC, Zirzow GC, Oliver K, Tedeschi G, Brady RO, Barton NW. Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease. Annals of Neurology. 42: 613-21. PMID 9382473 DOI: 10.1002/Ana.410420412  0.675
1996 Hill SC, Damaska BM, Tsokos M, Kreps C, Brady RO, Barton NW. Radiographic findings in type 3b Gaucher disease. Pediatric Radiology. 26: 852-60. PMID 8929296 DOI: 10.1007/Bf03178036  0.615
1996 Grabowski GA, Saal HM, Wenstrup RJ, Barton NW. Gaucher disease: a prototype for molecular medicine☆ Critical Reviews in Oncology Hematology. 23: 25-55. PMID 8817081 DOI: 10.1016/1040-8428(96)00199-0  0.325
1996 Brady RO, Barton NW. Enzyme replacement and gene therapy for Gaucher's disease. Lipids. 31: S137-9. PMID 8729108 DOI: 10.1007/Bf02637065  0.626
1996 Miller SP, Zirzow GC, Doppelt SH, Brady RO, Barton NW. Analysis of the lipids of normal and Gaucher bone marrow. The Journal of Laboratory and Clinical Medicine. 127: 353-8. PMID 8656038 DOI: 10.1016/S0022-2143(96)90183-3  0.595
1995 Ohshima T, Murray GJ, Nagle JW, Quirk JM, Kraus MH, Barton NW, Brady RO, Kulkarni AB. Structural organization and expression of the mouse gene encoding alpha-galactosidase A. Gene. 166: 277-80. PMID 8543175 DOI: 10.1016/0378-1119(95)00592-7  0.527
1995 Grabowski GA, Barton NW, Pastores G, Dambrosia JM, Banerjee TK, McKee MA, Parker C, Schiffmann R, Hill SC, Brady RO. Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources. Annals of Internal Medicine. 122: 33-9. PMID 7985893 DOI: 10.7326/0003-4819-122-1-199501010-00005  0.619
1995 Zimran A, Elstein D, Schiffmann R, Abrahamov A, Goldberg M, Bar-Maor JA, Brady RO, Guzzetta PC, Barton NW. Outcome of partial splenectomy for type I Gaucher disease. The Journal of Pediatrics. 126: 596-7. PMID 7699540 DOI: 10.1016/S0022-3476(95)70358-6  0.652
1995 Tedeschi G, Schiffmann R, Barton NW, Shih HH, Gospe SM, Brady RO, Alger JR, Di Chiro G. Proton magnetic resonance spectroscopic imaging in childhood ataxia with diffuse central nervous system hypomyelination. Neurology. 45: 1526-32. PMID 7644053 DOI: 10.1212/Wnl.45.8.1526  0.578
1994 Higgins JJ, Kaneski CR, Bernardini I, Brady RO, Barton NW. Pyridoxine-responsive hyper-beta-alaninemia associated with Cohen's syndrome. Neurology. 44: 1728-32. PMID 7936305 DOI: 10.1212/Wnl.44.9.1728  0.698
1993 Hill SC, Parker CC, Brady RO, Barton NW. MRI of multiple platyspondyly in Gaucher disease: response to enzyme replacement therapy. Journal of Computer Assisted Tomography. 17: 806-9. PMID 8370839 DOI: 10.1097/00004728-199309000-00026  0.62
1993 Castronovo FP, Mckusick KA, Doppelt SH, Barton NW. Radiopharmacology of inhaled 133Xe in skeletal sites containing deposits of Gaucher cells Nuclear Medicine and Biology. 20: 707-714. PMID 8358357 DOI: 10.1016/0969-8051(93)90042-S  0.375
1993 Banerjee TK, Grubb W, Otero C, McKee M, Brady RO, Barton NW. Musculocutaneous mononeuropathy complicating Capnocytophaga canimorsus infection. Neurology. 43: 2411-2. PMID 8232970 DOI: 10.1212/Wnl.43.11.2411  0.504
1993 Brady RO, Barton NW, Grabowski GA. The role of neurogenetics in Gaucher disease. Archives of Neurology. 50: 1212-24. PMID 8215980 DOI: 10.1001/Archneur.1993.00540110088009  0.663
1992 Barton NW, Brady RO, Dambrosia JM, Doppelt SH, Hill SC, Holder CA, Mankin HJ, Murray GJ, Zirzow GC, Parker RI. Dose-dependent responses to macrophage-targeted glucocerebrosidase in a child with Gaucher disease. The Journal of Pediatrics. 120: 277-80. PMID 1735829 DOI: 10.1016/S0022-3476(05)80444-5  0.566
1992 Higgins JJ, Patterson MC, Papadopoulos NM, Brady RO, Pentchev PG, Barton NW. Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration (HARP syndrome). Neurology. 42: 194-8. PMID 1734303 DOI: 10.1212/Wnl.42.1.194  0.711
1992 Hill SC, Damaska BM, Ling A, Patterson K, Di Bisceglie AM, Brady RO, Barton NW. Gaucher disease: abdominal MR imaging findings in 46 patients. Radiology. 184: 561-6. PMID 1620865 DOI: 10.1148/Radiology.184.2.1620865  0.616
1992 Parker RI, Grewal RP, McKeown LP, Barton NW. Effect of platelet count on the DDAVP-induced shortening of the bleeding time in thrombocytopenic Gaucher's patients. Journal of Pediatric Hematology Oncology. 14: 39-43. PMID 1550261 DOI: 10.1097/00043426-199221000-00005  0.361
1992 Higgins JJ, Patterson MC, Dambrosia JM, Pikus AT, Pentchev PG, Sato S, Brady RO, Barton NW. A clinical staging classification for type C Niemann-Pick disease. Neurology. 42: 2286-90. PMID 1461380 DOI: 10.1212/Wnl.42.12.2286  0.705
1992 Rosenthal DI, Barton NW, McKusick KA, Rosen BR, Hill SC, Castronovo FP, Brady RO, Doppelt SH, Mankin HJ. Quantitative imaging of Gaucher disease. Radiology. 185: 841-5. PMID 1438773 DOI: 10.1148/Radiology.185.3.1438773  0.601
1991 Barton NW, Brady RO, Dambrosia JM, Di Bisceglie AM, Doppelt SH, Hill SC, Mankin HJ, Murray GJ, Parker RI, Argoff CE. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease. The New England Journal of Medicine. 324: 1464-70. PMID 2023606 DOI: 10.1056/Nejm199105233242104  0.653
1991 Murray GJ, Howard KD, Richards SM, Barton NW, Brady RO. Gaucher's disease: lack of antibody response in 12 patients following repeated intravenous infusions of mannose terminal glucocerebrosidase. Journal of Immunological Methods. 137: 113-20. PMID 2010615 DOI: 10.1016/0022-1759(91)90400-A  0.621
1991 Parker RI, Barton NW, Read EJ, Brady RO. Hematologic improvement in a patient with Gaucher disease on long-term enzyme replacement therapy: evidence for decreased splenic sequestration and improved red blood cell survival. American Journal of Hematology. 38: 130-7. PMID 1951303 DOI: 10.1002/Ajh.2830380211  0.643
1991 Grewal RP, Doppelt SH, Thompson MA, Katz D, Brady RO, Barton NW. Neurologic complications of nonneuronopathic Gaucher's disease. Archives of Neurology. 48: 1271-2. PMID 1845033 DOI: 10.1001/Archneur.1991.00530240075025  0.647
1990 Barton NW, Furbish FS, Murray GJ, Garfield M, Brady RO. Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease. Proceedings of the National Academy of Sciences of the United States of America. 87: 1913-6. PMID 2308952 DOI: 10.1073/Pnas.87.5.1913  0.647
1989 Fink JK, Brouwers P, Barton N, Malekzadeh MH, Sato S, Hill S, Cohen WE, Fivush B, Gahl WA. Neurologic complications in long-standing nephropathic cystinosis. Archives of Neurology. 46: 543-8. PMID 2712751 DOI: 10.1001/Archneur.1989.00520410077027  0.341
1989 Brady RO, Filling-Katz MR, Barton NW, Pentchev PG. Niemann-Pick disease types C and D. Neurologic Clinics. 7: 75-88. PMID 2646522 DOI: 10.1016/S0733-8619(18)30829-6  0.596
1989 Filling-Katz MR, Merrick HF, Fink JK, Miles RB, Sokol J, Barton NW. Carbamazepine in Fabry's disease: effective analgesia with dose-dependent exacerbation of autonomic dysfunction. Neurology. 39: 598-600. PMID 2494569 DOI: 10.1212/Wnl.39.4.598  0.325
1989 Fink JK, Ravin P, Argoff CE, Levine RA, Brady RO, Hallett M, Barton NW. Tetrahydrobiopterin administration in biopterin-deficient progressive dystonia with diurnal variation. Neurology. 39: 1393-5. PMID 2477772 DOI: 10.1212/Wnl.39.10.1393  0.576
1988 Marti GE, Ryan ET, Papadopoulos NM, Filling-Katz M, Barton N, Fleischer TA, Rick M, Gralnick HR. Polyclonal B-cell lymphocytosis and hypergammaglobulinemia in patients with Gaucher disease American Journal of Hematology. 29: 189-194. PMID 3263798 DOI: 10.1002/Ajh.2830290403  0.367
1988 Fink JK, Barton N, Cohen W, Lovenberg W, Burns RS, Hallett M. Dystonia with marked diurnal variation associated with biopterin deficiency. Neurology. 38: 707-11. PMID 2452381 DOI: 10.1212/Wnl.38.5.707  0.331
1984 Pirruccello S, Barranger JA, Barton NW, Brady RO, Ginns EI. Molecular weight characterization of beta-D-glucocerebrosidase in mononuclear white blood cells in Gaucher's disease. Biochemical Medicine. 31: 73-9. PMID 6743300 DOI: 10.1016/0006-2944(84)90061-9  0.596
1984 Roberts MW, Barton NW, Constantopoulos G, Butler DP, Donahue AH. Occurrence of multiple dentigerous cysts in a patient with the Maroteaux-Lamy syndrome (mucopolysaccharidosis, type VI). Oral Surgery, Oral Medicine, and Oral Pathology. 58: 169-75. PMID 6435047 DOI: 10.1016/0030-4220(84)90133-6  0.403
Show low-probability matches.